查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1425000

CNS 特定反義寡核苷酸市場，按類型、按應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

CNS Specific Antisense Oligonucleotide Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 294 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年中樞神經系統特異性反義寡核苷酸市場規模為51.14億美元，2024年至2032年CAGR為22.5%。

CNS特異性反義寡核苷酸市場-市場動態

中樞神經系統疾病盛行率的增加預計將推動市場的成長

中樞神經系統特異性反義寡核苷酸為精準醫學提供了一種標靶治療方法，重點在於與中樞神經系統疾病相關的特定基因或路徑。與廣譜治療相比，這種方法有可能提供更有效、更安全的治療替代方案。根據聯合國最近的報告，大約有十億人（佔全球人口的近六分之一）患有神經系統疾病，如阿茲海默症、帕金森氏症、中風、多發性硬化症、癲癇、偏頭痛、腦損傷和神經感染。可悲的是，這些疾病每年奪走約 680 萬人的生命。此外，藥物輸送技術和研發投資的不斷進步為市場提供了有希望的成長機會。然而，與開發相關的高成本可能會阻礙市場成長。

CNS 特異性反義寡核苷酸市場 - 關鍵見解

根據研究分析師的分析，預計全球市場在預測期內（2024-2032年）每年將以 22.5%左右的CAGR成長

根據應用細分，線上藥局預計將在2023年佔據最大市場佔有率

依地區分類，北美是2023年的主要收入來源

CNS 特異性反義寡核苷酸市場-細分分析：

全球中樞神經系統特異性反義寡核苷酸市場根據類型、應用和區域進行細分。

市場依類型分為四類：多發性神經病變治療、脊髓性肌肉萎縮症（SMA）治療、亨丁頓舞蹈症治療。這些分類涵蓋各種神經系統疾病，目前研究中樞神經系統特異性 ASO 作為潛在的治療干預措施。重要的是要認知到藥物開發的前景可能會發生快速變化，並且此處提供的資訊可能會發生變化。

根據應用，市場分為三類：醫院藥局、零售藥局和網路藥局。該市場主要由線上藥局部門控制。這些數位平台為患者購買處方藥（包括用於治療神經系統疾病的處方藥）提供了便捷的解決方案，而無需親自前往傳統藥房。

中樞神經系統特異性反義寡核苷酸市場-地理洞察

中樞神經系統特異性反義寡核苷酸市場在地理上廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據參與商業活動的國家進一步分類。預計該市場的成長將由北美主導，這主要是由於反義藥物需求的增加和醫療保健支出的增加。北美，特別是美國和加拿大，擁有先進的醫療保健基礎設施，包括最先進的研究設施、臨床試驗能力和強大的監管框架。 《全球視野下的美國醫療保健》報告指出，2021年，美國醫療保健支出佔國內生產毛額（GDP）的17.8%，幾乎是經合組織國家平均水準的兩倍。此外，對先進治療干預措施的需求不斷成長，特別是對神經退化性疾病等具有挑戰性的疾病的治療，為採用中樞神經系統特異性反義寡核苷酸療法創造了有利的環境。此外，遞送技術的不斷進步和中樞神經系統特異性反義寡核苷酸療法的全球擴張可能為市場提供成長機會。然而，監管挑戰和安全擔憂可能會阻礙市場的成長。

中樞神經系統特異性反義寡核苷酸市場-競爭格局：

中樞神經系統特異性反義寡核苷酸市場的競爭格局見證了生物技術和製藥產業的顯著進步。這些進步是由針對疾病相關蛋白質的創新策略所推動的。然而，該領域新藥的開發需要投入大量的時間、精力和資源。因此，市場評估不同公司在中樞神經系統特異性反義寡核苷酸開發中所使用的技術平台非常重要。遞送方法、標靶特異性和新技術等因素在此評估中發揮關鍵作用。越來越多的核酸療法獲得批准，進一步強調了透過靶向體內基因藍圖來治療疾病的潛力。與主要針對蛋白質的傳統治療不同，這些療法具有解決疾病根本原因的優勢。 Wave Life Sciences 是這個市場上的一個著名參與者，這是一家專門從事 RNA 療法的生物技術公司。 Wave 將其管道專用於中樞神經系統特異性反義寡核苷酸，因此在這種背景下分析其技術平台和差異化策略非常重要。

最近的進展：

2023年 10月，Biogen Inc. 宣布了 BIIB080 的新 1b 期臨床資料，BIIB080 是一種針對輕度阿茲海默症的 tau 蛋白的研究性反義寡核苷酸療法。這些資料顯示了阿茲海默症患者的認知和日常活動的良好趨勢，先前的研究結果表明，腦脊髓液中的tau 蛋白濃度有所下降，不同大腦區域的tau 正子斷層掃描也顯示出這一結果。

目錄

第1章 中樞神經系統特異性反義寡核苷酸市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 依類型分類的CNS 特定反義寡核苷酸市場摘要
    • 依應用分類的CNS 特定反義寡核苷酸市場摘要
    • 依國家分類的CNS 特定反義寡核苷酸市場摘要
    • 依地區分類的中樞神經系統特異性反義寡核苷酸市場摘要
  • 競爭洞察

第3章 中樞神經系統特異性反義寡核苷酸主要市場趨勢

  • 中樞神經系統特異性反義寡核苷酸市場促進因素
    • 市場促進因素的影響分析
  • CNS特異性反義寡核苷酸市場限制
    • 市場限制影響分析
  • CNS特異性反義寡核苷酸市場機會
  • CNS特異性反義寡核苷酸市場未來趨勢

第4章 中樞神經系統特異性反義寡核苷酸產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 中樞神經系統特異性反義寡核苷酸市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 中樞神經系統特異性反義寡核苷酸市場格局

  • 2023年中樞神經系統特異性反義寡核苷酸市佔率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 中樞神經系統特異性反義寡核苷酸市場 - 依類型

  • 概述
    • 依類型分類的細分市場佔有率分析
    • 多發性神經病變治療
    • 脊髓性肌肉萎縮症（SMA）治療
    • 亨丁頓舞蹈症治療

第8章 中樞神經系統特異性反義寡核苷酸市場 -依應用

  • 概述
    • 依應用的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第9章 中樞神經系統特異性反義寡核苷酸市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 中樞神經系統特異性反義寡核苷酸北美主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依類型）
    • 北美市場規模和預測（依應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲中樞神經系統特異性反義寡核苷酸主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模與預測（依類型）
    • 歐洲市場規模和預測（依應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區中樞神經系統特異性反義寡核苷酸主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依類型）
    • 亞太地區市場規模與預測（依應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲中樞神經系統特異性反義寡核苷酸主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依類型）
    • 拉丁美洲市場規模與預測（依應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲中樞神經系統特異性反義寡核苷酸主要生產商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依類型）
    • 中東和非洲市場規模及預測（依應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA的其他地區

第10章 關鍵供應商分析 - CNS 特定反義寡核苷酸產業

  • 競爭儀表板
  • 公司簡介
    • Akcea Therapeutics, Inc.
    • Ionis Pharmaceuticals Inc.
    • Biogen Inc.
    • Sarepta Therapeutics
    • Wave Life Sciences Ltd.
    • Dynacure
    • ProQR Therapeutics NV
    • Stroke Therapeutic Inc.

第11章 360 度分析師視角

第12章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2200

REPORT HIGHLIGHT

CNS Specific Antisense Oligonucleotide Market size was valued at USD 5,114 Million in 2023, expanding at a CAGR of 22.5% from 2024 to 2032.

CNS-specific antisense oligonucleotides (ASOs) are a specific type of therapeutic agent that have been designed to target and regulate gene expression within the central nervous system. These ASOs are short, single-stranded DNA or RNA molecules that have the ability to selectively bind to complementary RNA sequences. This binding process can result in a range of cellular effects, including the degradation of the targeted RNA or the modulation of its splicing. The development of CNS-specific ASOs holds great promise for the treatment of previously challenging neurological disorders. By offering a targeted approach to modulating gene expression, these molecules have the potential to address the root causes of diseases rather than simply managing their symptoms. The FDA has already approved the use of ASOs for the treatment of ten genetic diseases, and ongoing research is exploring their potential for many more.

CNS Specific Antisense Oligonucleotide Market- Market Dynamics

Increasing Prevalence of CNS Disorders is projected to drive the growth of market

CNS-specific antisense oligonucleotides present a targeted therapeutic approach in precision medicine, focusing on specific genes or pathways implicated in CNS disorders. This method holds the potential to offer more effective and safer treatment alternatives compared to broad-spectrum treatments. According to a recent United Nations report, approximately one billion individuals, accounting for nearly one in six of the global population, suffer from neurological disorders such as Alzheimer's disease, Parkinson's disease, strokes, multiple sclerosis, epilepsy, migraines, brain injuries, and neuroinfections. Tragically, these maladies claim the lives of approximately 6.8 million people annually. Moreover, ongoing advancements in drug delivery technologies and research and development investments offer promising growth opportunities for the market. However, the high costs associated with development may impede market growth.

CNS Specific Antisense Oligonucleotide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.5% over the forecast period (2024-2032)

Based on Application segmentation, Online Pharmacies was predicted to show maximum market share in the year 2023

On the basis of region, North America was the leading revenue generator in 2023

CNS Specific Antisense Oligonucleotide Market- Segmentation Analysis:

The Global CNS Specific Antisense Oligonucleotide Market is segmented on the basis of Type, Application, and Region.

The market is segmented into four classifications according to Type: Polyneuropathy Treatment, Spinal Muscular Atrophy (SMA) Treatment, and Huntington's disease Treatment. These classifications encompass various neurological conditions, and CNS-specific ASOs are currently under investigation as potential therapeutic interventions. It is crucial to acknowledge that the landscape of drug development can undergo rapid changes, and the information presented here may be subject to alteration.

The market is divided into three categories based on application: Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. The market is predominantly controlled by the Online Pharmacies segment. These digital platforms offer a convenient solution for patients to purchase prescription medications, including those used to treat neurological disorders, without the need to physically visit a traditional pharmacy.

CNS Specific Antisense Oligonucleotide Market- Geographical Insights

CNS Specific Antisense Oligonucleotide market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing demand for antisense drugs and rising healthcare expenditure. North America, particularly the United States and Canada, has advanced healthcare infrastructure, including state-of-the-art research facilities, clinical trial capabilities, and a robust regulatory framework. In 2021, the U.S. spent 17.8 percent of its gross domestic product (GDP) on healthcare, which is nearly twice the average of OECD countries, as stated in the report U.S. Health Care from a Global Perspective. Additionally, the growing demand for advanced therapeutic interventions, especially for the treatment of challenging conditions like neurodegenerative disorders, creates a favorable environment for the adoption of CNS-specific antisense oligonucleotide therapies. Furthermore, the continuous advancements in delivery technologies and the global expansion of CNS-specific antisense oligonucleotide therapies may provide growth opportunities for the market. However, regulatory challenges and safety concerns could potentially hinder the market's growth.

CNS Specific Antisense Oligonucleotide Market- Competitive Landscape:

The competitive landscape of the CNS-Specific Antisense Oligonucleotide Market has witnessed significant advancements in the biotechnology and pharmaceutical industry. These advancements have been driven by innovative strategies aimed at targeting disease-related proteins. However, the development of new drugs in this field requires a substantial investment of time, effort, and resources. Therefore, it is crucial for the market to evaluate the technological platforms utilized by different companies in the development of CNS-specific antisense oligonucleotides. Factors such as delivery methods, targeting specificity, and novel technologies play a pivotal role in this assessment. The increasing number of approved nucleic acid therapeutics further emphasizes the potential of treating diseases by targeting their genetic blueprints in vivo. Unlike conventional treatments that primarily focus on proteins, these therapeutics offer the advantage of addressing the underlying causes of diseases. One notable player in this market is Wave Life Sciences, a biotechnology company specializing in RNA therapeutics. Wave has dedicated its pipeline to CNS-specific antisense oligonucleotides, making it essential to analyze their technology platform and differentiation strategies within this context.

Recent advancements:

In October 2023, Biogen Inc. announced new Phase 1b clinical data for BIIB080, an investigational antisense oligonucleotide therapy targeting tau in mild Alzheimer's disease. The data showed promising trends in cognition and daily activities among patients with Alzheimer's disease, building upon previous results that demonstrated a reduction in tau protein levels in the cerebral spinal fluid and tau positron emission tomography across different brain regions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Akcea Therapeutics, Inc.

Ionis Pharmaceuticals Inc.

Biogen Inc.

Sarepta Therapeutics

Wave Life Sciences Ltd.

Dynacure

ProQR Therapeutics N.V.

Stroke Therapeutic Inc.

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polyneuropathy Treatment
  • Spinal Muscular Atrophy (SMA) Treatment
  • Huntington's Disease Treatment

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CNS Specific Antisense Oligonucleotide Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CNS Specific Antisense Oligonucleotide Market Snippet by Type
    • 2.1.2. CNS Specific Antisense Oligonucleotide Market Snippet by Application
    • 2.1.3. CNS Specific Antisense Oligonucleotide Market Snippet by Country
    • 2.1.4. CNS Specific Antisense Oligonucleotide Market Snippet by Region
  • 2.2. Competitive Insights

3. CNS Specific Antisense Oligonucleotide Key Market Trends

  • 3.1. CNS Specific Antisense Oligonucleotide Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CNS Specific Antisense Oligonucleotide Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CNS Specific Antisense Oligonucleotide Market Opportunities
  • 3.4. CNS Specific Antisense Oligonucleotide Market Future Trends

4. CNS Specific Antisense Oligonucleotide Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CNS Specific Antisense Oligonucleotide Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. CNS Specific Antisense Oligonucleotide Market Landscape

  • 6.1. CNS Specific Antisense Oligonucleotide Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CNS Specific Antisense Oligonucleotide Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Polyneuropathy Treatment
    • 7.1.3. Spinal Muscular Atrophy (SMA) Treatment
    • 7.1.4. Huntington's Disease Treatment

8. CNS Specific Antisense Oligonucleotide Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharmacies
    • 8.1.4. Online Pharmacies

9. CNS Specific Antisense Oligonucleotide Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- CNS Specific Antisense Oligonucleotide Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Akcea Therapeutics, Inc.
    • 10.2.2. Ionis Pharmaceuticals Inc.
    • 10.2.3. Biogen Inc.
    • 10.2.4. Sarepta Therapeutics
    • 10.2.5. Wave Life Sciences Ltd.
    • 10.2.6. Dynacure
    • 10.2.7. ProQR Therapeutics N.V.
    • 10.2.8. Stroke Therapeutic Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE CNS Specific Antisense Oligonucleotide Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global CNS Specific Antisense Oligonucleotide Market, by Type 2019-2032 (USD Million)
  • TABLE CNS Specific Antisense Oligonucleotide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global CNS Specific Antisense Oligonucleotide Market, by Application 2019-2032 (USD Million)
  • TABLE CNS Specific Antisense Oligonucleotide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global CNS Specific Antisense Oligonucleotide Market, by Region 2019-2032 (USD Million)
  • TABLE North America CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE North America CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE CNS Specific Antisense Oligonucleotide Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Europe CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Asia Pacific CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Latin America CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Middle East and Africa CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE Germany CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE India CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE Brazil CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE Saudi Arabia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)